Literature DB >> 11050161

Amplification of dopaminergic signaling by a positive feedback loop.

A Nishi1, J A Bibb, G L Snyder, H Higashi, A C Nairn, P Greengard.   

Abstract

Dopamine and cAMP-regulated phosphoprotein of M(r) 32,000 (DARPP-32) plays an obligatory role in most of the actions of dopamine. In resting neostriatal slices, cyclin-dependent kinase 5 (Cdk5) phosphorylates DARPP-32 at Thr-75, thereby reducing the efficacy of dopaminergic signaling. We report here that dopamine, in slices, and acute cocaine, in whole animals, decreases the state of phosphorylation of striatal DARPP-32 at Thr-75 and thereby removes this inhibitory constraint. This effect of dopamine is achieved through dopamine D1 receptor-mediated activation of cAMP-dependent protein kinase (PKA). The activated PKA, by decreasing the state of phosphorylation of DARPP-32-Thr-75, de-inhibits itself. Dopamine D2 receptor stimulation has the opposite effect. The ability of activated PKA to reduce the state of phosphorylation of DARPP-32-Thr-75 is apparently attributable to increased protein phosphatase-2A activity, with Cdk5 being unaffected. Together, these results indicate that via positive feedback mechanisms, Cdk5 signaling and PKA signaling are mutually antagonistic.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11050161      PMCID: PMC18851          DOI: 10.1073/pnas.220410397

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

Review 1.  Brain protein serine/threonine phosphatases.

Authors:  N E Price; M C Mumby
Journal:  Curr Opin Neurobiol       Date:  1999-06       Impact factor: 6.627

Review 2.  Beyond the dopamine receptor: the DARPP-32/protein phosphatase-1 cascade.

Authors:  P Greengard; P B Allen; A C Nairn
Journal:  Neuron       Date:  1999-07       Impact factor: 17.173

3.  DARPP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1.

Authors:  H C Hemmings; P Greengard; H Y Tung; P Cohen
Journal:  Nature       Date:  1984 Aug 9-15       Impact factor: 49.962

4.  Opposing roles for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum.

Authors:  J C Stoof; J W Kebabian
Journal:  Nature       Date:  1981-11-26       Impact factor: 49.962

5.  Cables links Cdk5 and c-Abl and facilitates Cdk5 tyrosine phosphorylation, kinase upregulation, and neurite outgrowth.

Authors:  L R Zukerberg; G N Patrick; M Nikolic; S Humbert; C L Wu; L M Lanier; F B Gertler; M Vidal; R A Van Etten; L H Tsai
Journal:  Neuron       Date:  2000-06       Impact factor: 17.173

6.  Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons.

Authors:  J A Bibb; G L Snyder; A Nishi; Z Yan; L Meijer; A A Fienberg; L H Tsai; Y T Kwon; J A Girault; A J Czernik; R L Huganir; H C Hemmings; A C Nairn; P Greengard
Journal:  Nature       Date:  1999-12-09       Impact factor: 49.962

7.  Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration.

Authors:  G N Patrick; L Zukerberg; M Nikolic; S de la Monte; P Dikkes; L H Tsai
Journal:  Nature       Date:  1999-12-09       Impact factor: 49.962

8.  Regional distribution of calcium- and cyclic adenosine 3':5'-monophosphate-regulated protein phosphorylation systems in mammalian brain. II. Soluble systems.

Authors:  S I Walaas; A C Nairn; P Greengard
Journal:  J Neurosci       Date:  1983-02       Impact factor: 6.167

9.  DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. I. Regional and cellular distribution in the rat brain.

Authors:  S I Walaas; P Greengard
Journal:  J Neurosci       Date:  1984-01       Impact factor: 6.167

10.  DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein: regional, tissue, and phylogenetic distribution.

Authors:  H C Hemmings; P Greengard
Journal:  J Neurosci       Date:  1986-05       Impact factor: 6.167

View more
  75 in total

Review 1.  Activation of progestin receptors in female reproductive behavior: Interactions with neurotransmitters.

Authors:  Shaila Mani; Wendy Portillo
Journal:  Front Neuroendocrinol       Date:  2010-01-29       Impact factor: 8.606

2.  Role of aberrant striatal dopamine D1 receptor/cAMP/protein kinase A/DARPP32 signaling in the paradoxical calming effect of amphetamine.

Authors:  Francesco Napolitano; Alessandra Bonito-Oliva; Mauro Federici; Manolo Carta; Francesco Errico; Salvatore Magara; Giuseppina Martella; Robert Nisticò; Diego Centonze; Antonio Pisani; Howard H Gu; Nicola B Mercuri; Alessandro Usiello
Journal:  J Neurosci       Date:  2010-08-18       Impact factor: 6.167

3.  DARPP-32-like immunoreactivity in AII amacrine cells of rat retina.

Authors:  Gloria J Partida; Sherwin C Lee; Leah Haft-Candell; Grant S Nichols; Andrew T Ishida
Journal:  J Comp Neurol       Date:  2004-12-13       Impact factor: 3.215

Review 4.  Protein kinases and addiction.

Authors:  Anna M Lee; Robert O Messing
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

Review 5.  cAMP regulation of protein phosphatases PP1 and PP2A in brain.

Authors:  Shannon N Leslie; Angus C Nairn
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2018-09-18       Impact factor: 4.739

6.  Association between DARPP-32 gene polymorphism and personality traits in healthy Chinese-Han subjects.

Authors:  Jingying Li; Huan Ma; Hongxu Zhou; Yinglin Huang; Lijuan Wu; Jun Li; Gang Zhu
Journal:  J Mol Neurosci       Date:  2011-03-03       Impact factor: 3.444

7.  Hippocampal glycogen synthase kinase 3β is critical for the antidepressant effect of cyclin-dependent kinase 5 inhibitor in rats.

Authors:  Gang Li; Ting Liu; Xiangqian Kong; Lei Wang; Xing Jin
Journal:  J Mol Neurosci       Date:  2014-02-22       Impact factor: 3.444

8.  Phosphodiesterase 10A Is Tethered to a Synaptic Signaling Complex in Striatum.

Authors:  Corina Russwurm; Doris Koesling; Michael Russwurm
Journal:  J Biol Chem       Date:  2015-03-11       Impact factor: 5.157

Review 9.  Striatal glutamatergic mechanisms and extrapyramidal movement disorders.

Authors:  Thomas N Chase; Francesco Bibbiani; Justin D Oh
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

10.  Basal and cocaine-induced sex differences in the DARPP-32-mediated signaling pathway.

Authors:  Luyi Zhou; Arbi Nazarian; Wei-Lun Sun; Shirzad Jenab; Vanya Quinones-Jenab
Journal:  Psychopharmacology (Berl)       Date:  2008-11-05       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.